RENIN
发表于 2025-3-25 03:58:45
Clinical features and response to current treatment modalities in mantle cell lymphomaThis chapter addresses the important question of whether mantle cell lymphoma should be excluded from the indolent or low grade lymphomas, and presents strong evidence that it should be .
UTTER
发表于 2025-3-25 10:04:22
http://reply.papertrans.cn/43/4293/429295/429295_22.png
Intersect
发表于 2025-3-25 13:06:51
Transformed follicular lymphomaAny consideration of transformed follicular lymphoma has to address the problem of how to define “transformation” since this influences any assessment of its frequency as a complication of follicular lymphoma.
Morbid
发表于 2025-3-25 17:03:12
http://reply.papertrans.cn/43/4293/429295/429295_24.png
中止
发表于 2025-3-25 21:35:17
http://reply.papertrans.cn/43/4293/429295/429295_25.png
宽容
发表于 2025-3-26 01:41:21
Morphologic, immunologic and genetic features of follicular lymphoma, and the problem of gradingma, because it is composed of cells normally found in germinal centers, that is to say, both centrocytes and centroblasts. Also we require for the diagnosis a growth pattern which is (at least partially) follicular.
MENT
发表于 2025-3-26 04:21:18
Clinical aspects of follicular lymphoma and the relevance of gradinglar lymphoma is one of the commonest types of lymphomas, and one might hope that as a consequence, we could do better than we do in treating these patients. In practice, the ultimately poor clinical outcome makes this one of the most frustrating classes of lymphomas for clinicians.
Endemic
发表于 2025-3-26 09:38:20
http://reply.papertrans.cn/43/4293/429295/429295_28.png
Apoptosis
发表于 2025-3-26 12:58:27
Does nodal marginal zone lymphoma exist?tive study in the South West Oncology Group of indolent lymphomas diagnosed in the 1970s, we have gone into a jungle of boojum trees and yucca trees, but we have finally emerged triumphantly with some true primary nodal monocytoid B cell lymphomas.
amyloid
发表于 2025-3-26 18:36:22
A multi-institutional evaluation of lymphoma classificationle with the fact that morphology equated to outcome. The justification for this was the unique median survival of these patients. We had grown to live with some of the problems, not the least of which is that the original studies on which we have to rely were not based on uniformly staged and treated patients.